Sangamo Therapeutics (SGMO) Misses Q3 EPS by 27c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -5.7%
Financial Fact:
General and administrative: 5.02M
Today's EPS Names:
CRMT, More
Revenue Growth %: -5.7%
Financial Fact:
General and administrative: 5.02M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q3 EPS of ($0.59), $0.27 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $9.39 million versus the consensus estimate of $9.36 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg
- Elevance (ELV) PT Raised to $482 at Bernstein SocGen
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
